SLC3A2 and neoplasm: Similarly, SLC3A2 protein expression was associated with negative hormone status and HER2+ tumours (all p ≤ 0.001, Table 1) and it was highly expressed in TN compared with non-TN tumours (p < 0.001, Table 1).